Recreational cannabis has officially been legalized in Delaware.
Delaware became the 22nd state to legalize recreational cannabis in April 2023. While many celebrated cannabis’s liberation, not everyone was on board. One of these individuals being their governor (1).
The medicinal plant became legal for individuals over the age of 21. Governor John Carney (D) mentioned he still doesn’t support the recreastional use of cannabis but that the focus at the state level needs to fall to other issues. Gov. Carney has some fears for safety on roadways, children, and in poorer neighborhoods.
Delaware has not established dispensaries throughout the state yet. One bill that passed state legislature can create state-led regulations and licensing for manufacturing, cultivation, and retail.
Aside from Delaware, over 20 states have legalized recreational use. In New Jersey, cannabis sales have totaled over $228 million in 2022. Their state cannabis regulatory commission stated that the plant brought in nearly $20 million in tax revenue. The state of Delaware does not have a sales tax, which causes some uncertainty on how the state’s finances could be effected (1).
With cannabis legalized in Delaware, Pennsylvania is the now the only state in the Philly region who has not yet legalized cannabis. In Philadelphia, having a small amount of the plant has been decriminalized. All eyes are shifting to Pennsylvania to see if they will be next to approve of recreational use.
Reference
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.